In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life

References

• Loftsson T, Brewster ME. (2010). Pharmaceutical applications of cyclodextrins: basic science and product development. J Pharm Pharmacol, 62:1607–1621.
   PubMed Web of Science ®Google Scholar
• Rabinow BE. (2004). Nanosuspensions in drug delivery. Nat Rev Drug Discov, 3:785–796.
   PubMed Web of Science ®Google Scholar
• Veiga MD, Díaz PJ, Ahsan F. (1998). Interactions of griseofulvin with cyclodextrins in solid binary systems. J Pharm Sci, 87:891–900.
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci, 11 Suppl 2:S93–S98.
   PubMed Web of Science ®Google Scholar
• Christiansen A, Backensfeld T, Weitschies W. (2010). Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes. Eur J Pharm Sci, 41:376–382.
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci, 15:405–415.
   PubMed Web of Science ®Google Scholar
• Kuentz M. (2011). Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects. J Drug Deliv Sci Technol, 21:17–26.
   Web of Science ®Google Scholar
• Christensen JØ, Schultz K, Mollgaard B, Kristensen HG, Mullertz A. (2004). Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci, 23:287–296.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. (2007). The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm, 67:96–105.
   PubMed Web of Science ®Google Scholar
• Kaukonen AM, Boyd BJ, Porter CJ, Charman WN. (2004). Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res, 21:245–253.
   PubMed Web of Science ®Google Scholar
• Porter CJ, Kaukonen AM, Taillardat-Bertschinger A, Boyd BJ, O’Connor JM, Edwards GA et al. (2004). Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci, 93:1110–1121.
   PubMed Web of Science ®Google Scholar
• MacGregor KJ, Embleton JK, Lacy JE, Perry AE, Solomon J, Seager H, Pouton CW. (1997). Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Del Rev, 25:33–46.
   Web of Science ®Google Scholar
• Fernandez S, Chevrier S, Ritter N, Mahler B, Demarne F, Carrière F et al. (2009). In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14. Pharm Res, 26:1901–1910.
   PubMed Web of Science ®Google Scholar
• Reymond JP, Sucker H. (1988). In vitro model for ciclosporin intestinal absorption in lipid vehicles. Pharm Res, 5:673–676.
   PubMed Web of Science ®Google Scholar
• Sek L, Porter CJ, Kaukonen AM, Charman WN. (2002). Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol, 54:29–41.
   PubMed Web of Science ®Google Scholar
• Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L. (2001). A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci, 14:115–122.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Coacci J, Van den Mooter G. (2007). Correlation between digestion of the lipid phase of smedds and release of the anti-HIV drug UC 781 and the anti-mycotic drug enilconazole from smedds. Eur J Pharm Biopharm, 66:173–181.
   PubMed Web of Science ®Google Scholar
• Aloulou A, Rodriguez JA, Fernandez S, van Oosterhout D, Puccinelli D, Carrière F. (2006). Exploring the specific features of interfacial enzymology based on lipase studies. Biochim Biophys Acta, 1761:995–1013.
   PubMed Web of Science ®Google Scholar
• Panaiotov I, Ivanova M, Verger R. (1997). Interfacial and temporal organization of lipolysis. Curr Opin Colloid In, 2:517–525.
   Web of Science ®Google Scholar
• Verger R, de Haas GH. (1976). Interfacial enzyme kinetics of lipolysis. Annu Rev Biophys Bioeng, 5:77–117.
   PubMedGoogle Scholar
• Laidler KJ, Bunting PS. (1973). The chemical kinetics of enzyme action. Clarendon, Oxford.
   Google Scholar
• Kosugi Y, Suzuki H. (1983). New parameters for simulating progress curves of the lipase reaction. J Ferment Technol, 61:287–294.
   Google Scholar
• Knezevic ZD, Siler-Marinkovic SS, Mojovic LV. (1998). Kinetics of lipase-catalyzed hydrolysis of palm oil in lecithin/isooctane reversed micelles. Appl Microbiol Biotechnol, 49:267–271.
   Web of Science ®Google Scholar
• Embleton JK, Pouton CW. (1997). Structure and function of gastro-intestinal lipases. Adv Drug Del Rev, 25:15–32.
   Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, Dressman JB. (2008). Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res, 25:1663–1676.
   PubMed Web of Science ®Google Scholar
• Arnold Y, Gonzalez RB, Versace H, Kuentz M. (2010). Comparison of different in vitro tests to assess oral lipid-based formulations using a poorly soluble acidic drug. J Drug Del Sci Tech, 20:143–148.
   Web of Science ®Google Scholar
• Gargouri Y, Julien R, Bois AG, Verger R, Sarda L. (1983). Studies on the detergent inhibition of pancreatic lipase activity. J Lipid Res, 24:1336–1342.
   PubMed Web of Science ®Google Scholar
• Cuiné JF, McEvoy CL, Charman WN, Pouton CW, Edwards GA, Benameur H, Porter CJH. (2007). Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. J Pharm Sci, 97, 993–1010.
   Google Scholar
• Fatouros DG, Mullertz A. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol, 4:65–76.
   PubMed Web of Science ®Google Scholar
• Warren DB, Anby MU, Hawley A, Boyd BJ. (2011). Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. Langmuir, 27:9528–9534.
   PubMed Web of Science ®Google Scholar
• Ali H, Nazzal M, Zaghloul AA, Nazzal S. (2008). Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of α-tocopherol self-emulsified drug delivery systems (SEDDS). Int J Pharm, 352:104–114.
   PubMed Web of Science ®Google Scholar